Creighton University School of Medicine, Omaha, NE, USA.
Division of Clinical Research and Evaluative Sciences, 12282Creighton University School of Medicine, Department of Medicine, Creighton University School of Medicine, Omaha, NE, USA.
Int J Psychiatry Med. 2022 May;57(3):212-225. doi: 10.1177/00912174211028019. Epub 2021 Jun 26.
Heart Failure (HF) is one of the leading causes of hospitalization in the United States accounting for ≈800,000 hospital discharges and $11 billion in annual costs. Delirium occurs in approximately 30% of elderly hospitalized patients and its incidence is significantly higher among those admitted to the critical care units. Despite this, there has been limited exploration of the clinical and economic impact of delirium in patients hospitalized with acute HF. We hypothesized that delirium in HF is associated with excess mortality and hospital costs.
We queried the 2001-2014 Nationwide Inpatient Sample to identify hospitalizations that included a primary discharge diagnosis of HF (ICD-9-CM: 428.xx) and stratified them by presence or absence of delirium (ICD-9-CM: 239.0, 290.41, 293.0, 293.1, 348.31). Differences in in-hospital mortality, length of stay (LOS), and hospital costs were assessed using propensity-score matched cohorts.
Major predictors of delirium included advanced age, Caucasian race, underlying dementia or psychiatric diagnoses, higher Elixhauser Comorbidity Index, renal failure, cardiogenic shock, and coronary artery bypass surgery. In the propensity-score matched analysis of 76,411 hospitalization with delirium compared to 76,612 without delirium, in-hospital mortality (odds ratio: 1.67, 95% CI: 1.51-1.77), LOS (rate ratio [RR]: 1.47, 95% CI: 1.45-1.51), and hospital costs (RR: 1.44, 95% CI: 1.41-1.48) were all statistically higher in the presence of delirium (all p < 0.001).
In patients hospitalized with HF, delirium is an independent predictor of increased in-hospital mortality, longer LOS, and excess hospital costs despite adjustment for baseline characteristics.
心力衰竭(HF)是美国住院的主要原因之一,约有 800,000 例住院患者和 110 亿美元的年度费用。约 30%的老年住院患者会出现谵妄,而在入住重症监护病房的患者中,其发病率显著更高。尽管如此,对于急性 HF 住院患者中谵妄的临床和经济影响,研究仍十分有限。我们假设 HF 患者的谵妄与死亡率增加和住院费用增加有关。
我们查询了 2001 年至 2014 年的全国住院患者样本,以确定包括心力衰竭(ICD-9-CM:428.xx)主要出院诊断的住院患者,并根据是否存在谵妄(ICD-9-CM:239.0、290.41、293.0、293.1、348.31)对其进行分层。使用倾向评分匹配队列评估住院死亡率、住院时间(LOS)和住院费用的差异。
谵妄的主要预测因素包括年龄较大、白种人、潜在痴呆或精神科诊断、更高的 Elixhauser 合并症指数、肾衰竭、心源性休克和冠状动脉旁路手术。在 76411 例有谵妄的住院患者和 76612 例无谵妄的住院患者的倾向评分匹配分析中,住院死亡率(优势比:1.67,95%置信区间:1.51-1.77)、LOS(率比 [RR]:1.47,95%置信区间:1.45-1.51)和住院费用(RR:1.44,95%置信区间:1.41-1.48)在谵妄存在时均有统计学意义更高(均 p<0.001)。
在 HF 住院患者中,尽管调整了基线特征,但谵妄是住院死亡率增加、LOS 延长和住院费用增加的独立预测因素。